Metabolic Changes in Blood Samples From Patients With Acute Myeloid Leukemia
NCT02581917 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14
Last updated 2022-10-20
Summary
This research trial studies metabolic changes in blood samples from patients with acute myeloid leukemia. Studying samples of blood from patients with acute myeloid leukemia in the laboratory may help doctors learn more about cancer and the development of drug resistance.
Conditions
- Recurrent Adult Acute Myeloid Leukemia
- Untreated Adult Acute Myeloid Leukemia
Interventions
- OTHER
-
Cytology Specimen Collection Procedure
Undergo collection of PBMC samples
- OTHER
-
Laboratory Biomarker Analysis
Undergo metabolic analysis
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Wake Forest University Health Sciences
lead OTHER
Principal Investigators
-
Timothy Pardee · Wake Forest University Health Sciences
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-04-21
- Primary Completion
- 2021-04-01
- Completion
- 2022-04-30
Countries
- United States
Study Locations
More Related Trials
-
Biomarkers in Samples From Adult Patients With Acute Myeloid Leukemia Who Failed Existing Standard-of-Care Treatment
NCT01421862 ·Status: UNKNOWN
-
Biomarkers in Samples of Bone Marrow From Patients With Acute Myeloid Leukemia
NCT01290107 ·Status: COMPLETED
-
Membrane Target Detection for Leukemia Treatment
NCT04841447 ·Status: RECRUITING
-
Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia
NCT00898456 ·Status: ACTIVE_NOT_RECRUITING
-
Study of ADCT-301 in Patients With Relapsed/Refractory CD25-positive Acute Myeloid Leukemia (AML) or CD25-positive Acute Lymphoblastic Leukemia (ALL)
NCT02588092 ·Status: TERMINATED ·Phase: PHASE1
-
Leukemia Stem Cell Detection in Acute Myeloid Leukemia
NCT02927938 ·Status: TERMINATED ·Phase: PHASE3
-
Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia
NCT01385150 ·Status: COMPLETED
-
Studying Samples From Patients With T-Cell Acute Lymphoblastic Leukemia
NCT01581528 ·Status: COMPLETED
-
Characterization of T-cell Repertoire in Patients With Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant
NCT03921047 ·Status: RECRUITING
-
Analysis of T Cell Metabolism in Acute Myeloid Leukemia Patients
NCT04259372 ·Status: COMPLETED
-
Physical and Mental Assessment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
NCT00499785 ·Status: COMPLETED
-
Pilot Evaluation of a Microfluidic Assay to Detect Minimal Residual Disease and Predict Relapse in AML Patients
NCT03488862 ·Status: COMPLETED
-
Molecular Epidemiology of Therapy-related Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS)
NCT00525746 ·Status: UNKNOWN
-
Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
NCT02971397 ·Status: COMPLETED ·Phase: PHASE1
-
Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia
NCT00003931 ·Status: COMPLETED
-
High-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia
NCT00002865 ·Status: COMPLETED ·Phase: PHASE2
-
Development and Application of a Novel Digital Array PCR for Acute Myeloid Leukemia (AML)
NCT04920188 ·Status: TERMINATED
-
Phase I Study of Cell Therapies for the Treatment of Patients With Relapsed or Refractory AML or High-risk MDS
NCT05457010 ·Status: RECRUITING ·Phase: PHASE1
-
Donor Cellular Therapy After Cytarabine in Treating Patients With Intermediate-Risk Acute Myeloid Leukemia in Remission
NCT02587871 ·Status: WITHDRAWN ·Phase: PHASE2
-
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
NCT00048958 ·Status: ACTIVE_NOT_RECRUITING
-
Molecular Evaluation of AML Patients After Stem Cell Transplant to Understand Relapse Events
NCT05224661 ·Status: ACTIVE_NOT_RECRUITING
-
Refining the Role of Mid-induction Bone Marrow Biopsy in Acute Myeloid Leukemia: A Pilot Study
NCT06323590 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531
NCT01407757 ·Status: COMPLETED
-
Toxicity Genetic Determinants and Response to Azacitidine and Venetoclax in AML
NCT06580106 ·Status: RECRUITING
-
AML-MDS Novel Prognostic Tests Clinical Study
NCT01685619 ·Status: COMPLETED